Portage biotech reports results for fiscal quarter ended september 30, 2024

Westport, conn., nov. 26, 2024 (globe newswire) -- portage biotech inc. (“portage” or the “company”) (nasdaq: prtg), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today reported its financial results for the fiscal quarter ended september 30, 2024.
ATON Ratings Summary
ATON Quant Ranking